期刊文献+

霍乱弧菌封闭带毒素功能片段△G的原核表达及其免疫增强活性

Prokaryotic expression of the active fragment ΔG of zonula occludens toxin gene of Vibrio cholerae and analysis of immunity-enhancing effect of its expressed product
在线阅读 下载PDF
导出
摘要 用PCR扩增了MBP—ZOT质粒上的ZOT基因,该基因编码264~399位氨基酸残基C末端的15ku △G片段,并与经改造后的质粒P^BCX、连接。将重组后的质粒PMLAG在大肠杆菌BL21中表达,将表达的目的蛋白纯化,再将p^BCX-△G片段与传染性腔上囊炎病毒VP2包涵体蛋白通过滴鼻免疫途径对14日龄SPF鸡进行联合免疫试验,分别于免疫后第10、20d采集血清样品,进行ELISA试验,检测免疫后IBD抗体效价。动物免疫试验发现:融合蛋白P^BCX △G起到了明显免疫增强效果,与VP2重组蛋白联合免疫2次后,血清IBD的VP2 IgG抗体效价是单独用VP2免疫组的3倍,明显高于空白免疫组。 The carboxyl-terminal fragment of approximately 15 ku of zonula occludens toxin(ZOT) gene encoding the 264-399 amino acid residue was amplified by PCR and then cloned into the prokaryotic expression plasmids p^BCX. The active protein expressed in Escherichia coli was purified. The inclusion body from VP2 gene of infectious bursal disease vir'us(IBDV) was used to intranasally vaccinate the 14-day-old SPF chickens, combined with purified protein P^BCX △G, with a booster 10 days later. The serum samples were collected every 10 days after the last immunization. ELISA were used to detect the IBD antibodies titer of anti-VP2. The results showed that the fusion protein P^BCX △G exhibited an adjuvant activity. The IBD antibody titer of VP2 in the chickens immunized with VP2 in the presence P^BCX △G was approxi- mately 3-fold higher than those of the control group after the second immunization.
出处 《中国兽医科学》 CAS CSCD 北大核心 2007年第2期135-139,共5页 Chinese Veterinary Science
基金 广东省农业攻关项目(2002B21404)
关键词 霍乱弧菌 封闭带毒素 原核表达 传染性腔上囊炎 免疫 Vibrio cholerae zonula occludens toxin prokaryotic expression infectious bursal disease immunization
  • 相关文献

参考文献12

  • 1FASANO A,BAUDRY B,PUMPLIN D W,et al.Vibrio cholerae produces a second enterotoxin,which affects intestinal tight junctions[J].Proc Natl Acad Sci USA,1991,88 (10):5242-5246.
  • 2MARINAROSARIA T,DI PIERRO Y,RULIANG H,et al.Zonula occludens toxin structure-function analysis:identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain[J].Biol Chem,2001,276(22):19160-19165.
  • 3曹永长,毕英佐.封闭带毒素[J].生物技术通讯,2003,14(1):64-66. 被引量:3
  • 4MC GHEE J R,MESTEVKY J R,DERTZBAUGH M T,et al.The mucosal immune system:from fundamental concepts to vaccine development[J].Vaccine,1992,10 (2):75-88.
  • 5裴永峰,李劲松.吸入免疫研究进展[J].生物技术通讯,2004,15(1):76-78. 被引量:2
  • 6KAWABATA S,TERAO Y,FUJIWARA T,et al.Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice[J].Infect Immun,1999,67(11):5863-5868.
  • 7夏肖萍,严杰,钊守凤,毛亚飞,李淑萍.大肠杆菌LTB与霍乱弧菌CTB基因的克隆和表达及鉴定[J].浙江大学学报(医学版),2003,32(1):17-20. 被引量:9
  • 8夏肖萍,胡野,严杰.大肠杆菌重组LTKA63突变体和LTB黏膜免疫佐剂活性的研究[J].中华微生物学和免疫学杂志,2006,26(4):354-359. 被引量:3
  • 9YAMAMOTO M,MCGHEE J R,HAGIWARA Y H,et al.Genetically manipulated bacterial toxin as a new generation mucosal adjuvant[J].Scand J Immunol,2001,53 (3):211-217.
  • 10FASANO A,FIORENTINI C,DONELLI G,et al.Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization in vitro[J].Clin Invest,1995,96(7):710-720.

二级参考文献78

  • 1[1]Verweij W R, de Haan L, Marijke H, et al. Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen [J]. Vaccine, 1998,16(20):2069-2076.
  • 2[2]Kunio T, Masanori I, Yoko Y, et al. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin [J]. Vaccine, 1997,16(2/3):150-155.
  • 3[3]Yamamoto M, Mcghee J R, Hagiwara Y H, et al. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant [J]. Scand J Immunol, 2001,53(3):211-217.
  • 4[4]de Haan K, Feil I K, Verweij W R, et al. Mutational analysis of the role ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin [J]. Eur J Immunol, 1998,28(4):1243-1250.
  • 5[5]Saito K, Shoji J, Inada N, et al. Immunosuppressive effect of cholera toxin B on allergic conjunctivitis model in guinea pig [J]. Japanese J Ophthamol, 2001,45(4):332-338.
  • 6[6]de Haan L, Verweij W R, Feil I K, et al. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit [J]. Immunology, 1998 Jul,94(3):424-430.
  • 7[7]Sambrook J, Fritsch E F, Maniatis T. Molecular Clo-ning, A Laboratory Manual [M]. 2nd edition. New York: Cold Spring Harbor Laboratory Press, 1989.
  • 8[8]de Haan L, Holtrop M, Verweij W R, et al. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit [J].Vaccine, 1996,14(4):260-266.
  • 9[9]Douce G, Fontana M, Pizza M, et al. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin [J]. Infect Immun, 1997,65(7):2821-2828.
  • 10[10]Yamamoto S, Takeda Y, Yamamoto M, et al. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity [J]. J Exp Med, 1997,185(7):1203-1210.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部